MedTrace Logo

Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients

NCT05354427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-09-16

No results posted yet for this study

Summary

Assessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.

Conditions

Interventions

OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with implantabale spacers.

Sponsors & Collaborators

  • BioProtect

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • Poland
  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05354427 on ClinicalTrials.gov